Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF

Abroad (travel likely)RecruitingPHASE3

Conditions

Idiopathic Pulmonary Fibrosis (IPF)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

China-Japan Friendship Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (huaping Dai, PhD) · daihuaping@ccmu.edu.cn · 86-010-84206271

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis (IPF)

Abroad (travel likely)RecruitingPHASE3

Palm Spring, United States · Redding, United States

Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole

Idiopathic Pulmonary Fibrosis

Abroad (travel likely)RecruitingPHASE3

Norwich, United Kingdom · Aberdeen, United Kingdom

SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

Abroad (travel likely)RecruitingPHASE2, PHASE3

Beijing, China

A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Abroad (travel likely)RecruitingPHASE2

Skopje, North Macedonia